Baker Avenue Asset Management, LP

Position in GILD — Gilead Sciences, Inc.

CIK 1432529 SAN FRANCISCO, CA

Position in GILD

as of Jun 30, 2026 · filed Jul 28, 2026 Compact

Position Value

$7,497,899

+$6,676,313 QoQ

Shares Held

59,347

+906.7% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.23%

of 13F equity value

Holder Rank

#487

of 2,266 holders

Holding Since

Sep 2021

13 quarters on record

Voting authority Sole 67% Shared 0% None 33%

Healthcare · as of Jun 30, 2026

Baker Avenue Asset Management, LP holds $87,152,887 across 10 Drug Manufacturers - General names. GILD ranks #4 (8.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	26,531	$31,822,079
2	ABBV	AbbVie Inc.	85,535	$21,524,027
3	JNJ	Johnson & Johnson	43,298	$10,996,393
4	GILD	Gilead Sciences, Inc. This page	59,347	$7,497,899
5	MRK	Merck & Co., Inc.	51,784	$6,654,244
6	AMGN	Amgen Inc	15,621	$5,656,676
7	BMY	Bristol Myers Squibb Co	17,475	$1,006,909
8	PFE	Pfizer Inc	40,733	$980,850

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,497,899	59,347	+906.7%	Shares	Sole	2026-07-28
2026-03-31	$821,586	5,895	+222.5%	Shares	Sole	2026-05-12
2025-12-31	$224,368	1,828	-41.0%	Shares	Sole	2026-02-10
2025-09-30	$344,100	3,100	+8.6%	Shares	Sole	2025-10-31
2025-06-30	$316,533	2,855	+14.7%	Shares	Sole	2025-08-13
2025-03-31	$279,004	2,490	+316.4%	Shares	Sole	2025-05-08
2023-09-30	$44,814	598	-19.5%	Shares	Sole	2023-11-15
2023-06-30	$57,263	743	+23.4%	Shares	Sole	2023-08-14
2023-03-31	$49,947	602	+113.5%	Shares	Sole	2023-05-16
2022-12-31	$24,209	282	-94.1%	Shares	Sole	2023-02-14
2022-03-31	$285,360	4,800	+23.1%	Shares	Sole	2022-05-16
2021-12-31	$283,106	3,899	+11.4%	Shares	Sole	2022-02-11
2021-09-30	$244,475	3,500	—	Shares	Sole	2021-11-15
No filing history on record for this holder in this stock.